First Time Loading...

Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 9.4 HKD 2.73% Market Closed
Updated: Jun 11, 2024

Genscript Biotech Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genscript Biotech Corp
Operating Income Peer Comparison

Comparables:
603259
300759
2269
300347
M
688114

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Genscript Biotech Corp
HKEX:1548
Operating Income
-$387.4m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Operating Income
¥10.9B
CAGR 3-Years
43%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Operating Income
¥1.7B
CAGR 3-Years
11%
CAGR 5-Years
29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Operating Income
¥4.1B
CAGR 3-Years
36%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Operating Income
¥1.6B
CAGR 3-Years
19%
CAGR 5-Years
25%
CAGR 10-Years
32%
M
MGI Tech Co Ltd
SSE:688114
Operating Income
¥190.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genscript Biotech Corp's Operating Income?
Operating Income
-387.4m USD

Based on the financial report for Dec 31, 2023, Genscript Biotech Corp's Operating Income amounts to -387.4m USD.

What is Genscript Biotech Corp's Operating Income growth rate?
Operating Income CAGR 3Y
-23%

Over the last year, the Operating Income growth was 10%. The average annual Operating Income growth rates for Genscript Biotech Corp have been -23% over the past three years .